RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Eckert & Ziegler Stock

Eckert & Ziegler Liabilities 2024

Eckert & Ziegler Liabilities

217.19 M EUR

Ticker

EUZ.DE

ISIN

DE0005659700

WKN

565970

In 2024, Eckert & Ziegler's total liabilities amounted to 217.19 M EUR, a 11.16% difference from the 195.39 M EUR total liabilities in the previous year.

Eckert & Ziegler Aktienanalyse

What does Eckert & Ziegler do?

The Eckert & Ziegler Strahlen und Medizintechnik AG is an international company that offers both medical and industrial products and services in the field of radiation application. The company was founded in 1997 and has its headquarters in Berlin. The history of the company began in the 1960s when the two founders, Dr. Andreas Eckert and Dr. Edgar Ziegler, started producing medical isotopes for the diagnosis and therapy of cancer patients. After initially working in a laboratory in Berlin, they founded Eckert & Ziegler Isotope Products GmbH in 1983. In the following years, the company expanded and added radiation sources for industrial applications to its portfolio. In 1997, Eckert & Ziegler Strahlen und Medizintechnik AG was founded to consolidate the two business areas and expand the international business. Today, the company operates worldwide and employs over 800 people. The company's business model focuses on the application of radiation in various industries. The company relies on different business areas that can be divided into medical and industrial applications. In the medical field, Eckert & Ziegler develops and produces radiation sources for the diagnosis and therapy of cancer and other diseases. The products include radioactive isotopes used for the production of medications, the equipment of clinics, and research. Particularly important are radioactive substances for the treatment of prostate cancer, which are highly sought after due to their high effectiveness in patients. In the field of industrial applications, the company offers radiation sources for various industries, such as medical imaging, sterilization of medical devices, or non-destructive testing of materials in the automotive and aviation industries. The company also develops customized solutions for specific customer needs. Another important business area is the disposal of radioactive waste. Here, the company offers solutions for hospitals, research institutions, and companies that work with radioactive substances and must comply with legal requirements for disposal. Eckert & Ziegler is a company that focuses on innovation and research. The company continuously invests in research and development to keep its products and services up to date. For this purpose, the company maintains close relationships with research institutions and universities to develop new technologies and products. The company also strives to make its products and services environmentally friendly and sustainable. It relies on the use of renewable energies, energy efficiency, and recyclability of products. Overall, Eckert & Ziegler Strahlen und Medizintechnik AG is a leading company in the application of radiation in medical and industrial applications. The company relies on innovative products and solutions to meet the needs of its customers. Eckert & Ziegler ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Liabilities Details

Assessing Eckert & Ziegler's Liabilities

Eckert & Ziegler's liabilities constitute the company's financial obligations and debts owed to external parties and stakeholders. They are categorized into current liabilities, due within a year, and long-term liabilities, which are due over a longer period. A detailed assessment of these liabilities is crucial for evaluating Eckert & Ziegler's financial stability, operational efficiency, and long-term viability.

Year-to-Year Comparison

By comparing Eckert & Ziegler's liabilities year-over-year, investors can identify trends, shifts, and anomalies in the company’s financial positioning. A decrease in total liabilities often signals financial strengthening, while an increase might indicate enhanced investments, acquisitions, or potential financial strain.

Impact on Investments

Eckert & Ziegler's total liabilities play a significant role in determining the company's leverage and risk profile. Investors and analysts examine this aspect meticulously to ascertain the firm’s ability to meet its financial obligations, which influences investment attractiveness and credit ratings.

Interpreting Liability Fluctuations

Shifts in Eckert & Ziegler’s liability structure indicate changes in its financial management and strategy. A reduction in liabilities reflects efficient financial management or debt payoffs, while an increase may suggest expansion, acquisition activities, or accruing operational expenses, each carrying distinct implications for investors.

Frequently Asked Questions about Eckert & Ziegler stock

What is the level of liabilities of Eckert & Ziegler this year?

Eckert & Ziegler has a debt balance of 217.19 M EUR this year.

What were the liabilities of Eckert & Ziegler compared to the previous year?

The liabilities of Eckert & Ziegler have increased by 11.16% increased compared to the previous year.

What are the consequences of high debt for investors of Eckert & Ziegler?

High liabilities can pose a risk for investors of Eckert & Ziegler, as they can weaken the company's financial position and impair its ability to meet its obligations.

What consequences do low liabilities have for investors in Eckert & Ziegler?

Low liabilities mean that Eckert & Ziegler has a strong financial position and is able to meet its obligations without overburdening its finances.

How does an increase in liabilities of Eckert & Ziegler affect the company?

An increase in liabilities of Eckert & Ziegler can lead to the company having more obligations and potentially find it more difficult to meet its financial commitments.

How does a reduction in the liabilities of Eckert & Ziegler affect the company?

A decrease in the liabilities of Eckert & Ziegler can lead to the company having fewer obligations and a stronger financial position, which can make it easier for the company to fulfill its financial commitments.

What are some factors that influence the liabilities of Eckert & Ziegler?

Some factors that can influence the liabilities of Eckert & Ziegler include investments, acquisitions, operating costs, and sales development.

Why is the level of liabilities of Eckert & Ziegler so important for investors?

The liabilities of Eckert & Ziegler are important for investors as they serve as an indicator of the company's financial stability and provide investors with information on how the company meets its financial obligations.

What strategic measures can Eckert & Ziegler take to modify the liabilities?

To change its liabilities, Eckert & Ziegler can take measures such as cost savings, increasing revenue, selling assets, raising investments, or forming partnerships. It is important for the company to conduct a thorough review of its financial situation to choose the best strategic actions.

How much dividend does Eckert & Ziegler pay?

Over the past 12 months, Eckert & Ziegler paid a dividend of 0.5 EUR . This corresponds to a dividend yield of about 1.12 %. For the coming 12 months, Eckert & Ziegler is expected to pay a dividend of 0.55 EUR.

What is the dividend yield of Eckert & Ziegler?

The current dividend yield of Eckert & Ziegler is 1.12 %.

When does Eckert & Ziegler pay dividends?

Eckert & Ziegler pays a quarterly dividend. This is distributed in the months of July, July, June, July.

How secure is the dividend of Eckert & Ziegler?

Eckert & Ziegler paid dividends every year for the past 23 years.

What is the dividend of Eckert & Ziegler?

For the upcoming 12 months, dividends amounting to 0.55 EUR are expected. This corresponds to a dividend yield of 1.22 %.

In which sector is Eckert & Ziegler located?

Eckert & Ziegler is assigned to the 'Health' sector.

Wann musste ich die Aktien von Eckert & Ziegler kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Eckert & Ziegler from 7/1/2024 amounting to 0.05 EUR, you needed to have the stock in your portfolio before the ex-date on 6/27/2024.

When did Eckert & Ziegler pay the last dividend?

The last dividend was paid out on 7/1/2024.

What was the dividend of Eckert & Ziegler in the year 2023?

In the year 2023, Eckert & Ziegler distributed 0.5 EUR as dividends.

In which currency does Eckert & Ziegler pay out the dividend?

The dividends of Eckert & Ziegler are distributed in EUR.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

The Eckert & Ziegler stock can be added to a savings plan with the following providers: Trade Republic, Scalable Capital and Consorsbank

Andere Kennzahlen von Eckert & Ziegler

Our stock analysis for Eckert & Ziegler Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Eckert & Ziegler Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.